Molson Coors Says ‘Volatile Times,' Not Ozempic, Dim Its Beer Outlook [BNN Bloomberg (Canada)]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: BNN Bloomberg
“We don't have data to suggest that's having a meaningful impact on the alcohol space,” CEO Gavin Hattersley said on an earnings call Tuesday. “I do think we're living in more volatile times.” Hattersley said inflation has been “more sticky” than expected, according to a transcript of the call. “I do see cautious behavior from consumers,” he said, adding that the summer season will determine where the industry lands for the full year. Molson has said its brands have benefited from competitor Bud Light's loss of shelf space, but its shares fell after its first-quarter report Tuesday as it reiterated its guidance for 2024. The company said it has grown “incrementally more cautious” on its outlook for the year given early-April industry performance. Hattersley said that April was “choppy” for the entire industry, and blamed the timing of the Easter holiday, which came earlier this year. People typically consume less beer around the holiday. Some users of GLP-1 drugs that aid wei
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- This overlooked obesity-drug stock has 80% upside, JPMorgan says [Yahoo! Finance]Yahoo! Finance
- Australia to Ban Copycats of Ozempic Weight Loss Medication [BNN Bloomberg (Canada)]BNN Bloomberg
- Senators place blame for sky-high drug prices on abuse of the patent system [MSNBC.com]MSNBC.com
- Hims & Hers rolls out weight-loss shots much cheaper than Ozempic, Wegovy [Yahoo! Finance]Yahoo! Finance
- Nestlé's new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 5/3/24 - Beat
NVO
Sec Filings
- 5/17/24 - Form 6-K
- 5/17/24 - Form SD
- 5/15/24 - Form 6-K
- NVO's page on the SEC website